Clorox Secures $2.25B Credit Facilities to Acquire PURELL Maker GOJO Industries

Clorox Company (NYSE: CLX) has secured $2.25 billion in credit facilities to finance its acquisition of GOJO Industries, the maker of PURELL hand sanitizer, according to an 8-K filing with the SEC on March 10, 2026.

The Deal

The consumer products giant entered into two separate credit agreements on March 6, 2026, to fund the purchase of all membership interests in GOJO Industries. The financing package consists of a $1.25 billion delayed draw term credit agreement specifically designated for the acquisition and a $1 billion 364-day revolving credit facility for general corporate purposes.

JPMorgan Chase Bank, Citibank, and Wells Fargo Bank are serving as joint lead arrangers and administrative agents for both facilities. The delayed draw term loans must be used by December 31, 2026, or upon termination of the acquisition agreement, whichever comes first. The term loans mature on March 5, 2027, while the revolving credit can be extended to March 5, 2028, if converted to a term loan.

Both credit facilities are senior unsecured obligations with no guarantees required from Clorox subsidiaries. The company can choose between base rate or Term SOFR-based pricing, with margins dependent on Clorox's credit rating. The agreements include standard covenants for investment-grade borrowers, with the only financial covenant being a consolidated interest coverage ratio.

Strategic Rationale

The acquisition of GOJO represents a significant expansion of Clorox's presence in the commercial cleaning and hygiene market. PURELL, which became a household name during the COVID-19 pandemic, dominates the professional hand sanitizer market with strong distribution in healthcare facilities, offices, schools, and restaurants.

For Clorox, already a leader in consumer disinfecting products through its namesake bleach and wipes brands, adding PURELL creates immediate synergies in distribution and procurement. The professional hygiene market offers higher margins and more stable demand patterns than retail consumer products, potentially improving Clorox's overall profitability profile.

The financing structure suggests confidence in quick deal closure. The delayed draw feature allows Clorox to avoid paying interest until funds are actually needed at closing, while the additional revolving facility provides flexibility for integration costs and working capital needs. The relatively short maturity of March 2027 indicates management expects to refinance with permanent debt once the acquisition is integrated.

What to Watch

Several factors will determine the success of this transaction. First, regulatory approval timing remains uncertain, though the December 31, 2026 commitment expiration suggests Clorox expects a decision within nine months. Given the complementary nature of the businesses—Clorox focuses on consumer retail while GOJO dominates professional channels—antitrust concerns appear limited.

The credit agreements include automatic reduction provisions if Clorox raises equity or issues other debt, signaling potential for a more permanent financing solution post-closing. With interest rates elevated, the company may pursue bond offerings if market conditions improve, using proceeds to pay down the acquisition financing.

Integration execution will be critical. GOJO has operated as a family-owned business for nearly 80 years, presenting cultural integration challenges. Clorox will need to retain GOJO's professional sales force and distribution relationships while finding cost synergies in manufacturing and procurement.

The financial covenant requiring only interest coverage maintenance provides Clorox significant operational flexibility during integration. However, the company's leverage will increase substantially, likely pushing debt-to-EBITDA ratios above 3x initially. Credit rating agencies will closely monitor integration progress and synergy realization.

Market conditions for hygiene products have normalized since pandemic peaks, making the purchase price and expected returns crucial metrics that haven't been disclosed. Investors should watch for details on valuation multiples and synergy targets when Clorox formally announces the transaction.

The involvement of three major banks as joint leads suggests strong lender confidence in both Clorox's credit profile and the strategic merit of the acquisition. The competitive terms, including no guarantee requirements and a single financial covenant, reflect Clorox's strong investment-grade standing despite the sizeable acquisition financing.

*Source: SEC Form 8-K filed March 10, 2026*

— StockCliff Research